Loading...
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
PURPOSE: This study was conducted to evaluate the relationship between epidermal growth factor receptor (EGFR) mutation and clinical outcomes in patients with stage III non-squamous cell lung cancer treated with definitive concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: From January 2008...
Na minha lista:
| Udgivet i: | Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Cancer Association
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6473280/ https://ncbi.nlm.nih.gov/pubmed/29914238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2018.125 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|